Insulin signaling and glucose homeostasis in mice lacking protein tyrosine phosphatase α

Biochemical and Biophysical Research Communications

Volumn 314, Issue 2, 2004, Pages 321-329

  Le, Hoa T ^a   Ponniah, Sathivel ^b   Pallen, Catherine J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Insulin action; Insulin receptor; IRS; PI 3 K; PTP; Tyrosine phosphorylation

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GENE TARGETING; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; INSULIN METABOLISM; INSULIN TOLERANCE TEST; LIVER; MOUSE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALIA;

EID: 0347004670     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.087     Document Type: Article

References (36)

1. Mauvais-Jarvis F., Kulkarni R.N., Kahn C.R. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin. Endocrinol. 57:2002;1-9.
2. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 104:2001;517-529.
3. Saltiel A.R., Pessin J.E. Insulin signaling pathways in time and space. Trends Cell Biol. 12:2002;65-71.
4. Virkamaki A., Ueki K., Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103:1999;931-943.
5. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283:2002;E413-E422.
6. Asante-Appiah E., Kennedy B.P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 284:2003;E663-E670.
7. Cheng A., Dube N., Gu F., Tremblay M.L. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur. J. Biochem. 269:2002;1050-1059.
8. Elchebly M., Cheng A., Tremblay M.L. Modulation of insulin signaling by protein tyrosine phosphatases. J. Mol. Med. 78:2000;473-482.
9. Galic S., Klingler-Hoffmann M., Fodero-Tavoletti M.T., Puryer M.A., Meng T.C., Tonks N.K., Tiganis T. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol. Cell. Biol. 23:2003;2096-2108.
10. Ahmad F., Goldstein B.J. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. J. Biol. Chem. 272:1997;448-457.
11. Bandyopadhyay D., Kusari A., Kenner K.A., Liu F., Chernoff J., Gustafson T.A., Kusari J. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J. Biol. Chem. 272:1997;1639-1645.
12. Boute N., Boubekeur S., Lacasa D., Issad T. Dynamics of the interaction between the insulin receptor and protein-tyrosine phosphatase 1B in living cells. EMBO Rep. 4:2003;313-319.
13. Dadke S., Kusari J., Chernoff J. Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region. J. Biol. Chem. 275:2000;23642-23647.
14. Seely B.L., Staubs P.A., Reichart D.R., Berhanu P., Milarski K.L., Saltiel A.R., Kusari J., Olefsky J.M. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes. 45:1996;1379-1385.
15. Walchli S., Curchod M.L., Gobert R.P., Arkinstall S., Hooft van Huijsduijnen R. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate- trapping" mutants. J. Biol. Chem. 275:2000;9792-9796.
16. Kuhne M.R., Pawson T., Lienhard G.E., Feng G.S. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268:1993;11479-11481.
17. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 283:1999;1544-1548.
18. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20:2000;5479-5489.
19. Zinker B.A., Rondinone C.M., Trevillyan J.M., Gum R.J., Clampit J.E., Waring J.F., Xie N., Wilcox D., Jacobson P., Frost L., Kroeger P.E., Reilly R.M., Koterski S., Opgenorth T.J., Ulrich R.G., Crosby S., Butler M., Murray S.F., McKay R.A., Bhanot S., Monia B.P., Jirousek M.R. PTP1B antisense oligonucleotide lowers PTP 1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA. 99:2002;11357-11362.
20. Gum R.J., Gaede L.L., Koterski S.L., Heindel M., Clampit J.E., Zinker B.A., Trevillyan J.M., Ulrich R.G., Jirousek M.R., Rondinone C.M. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes. 52:2003;21-28.
21. Ren J.M., Li P.M., Zhang W.R., Sweet L.J., Cline G., Shulman G.I., Livingston J.N., Goldstein B.J. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes. 47:1998;493-497.
22. Schaapveld R.Q., Schepens J.T., Robinson G.W., Attema J., Oerlemans F.T., Fransen J.A., Streuli M., Wieringa B., Hennighausen L., Hendriks W.J. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev. Biol. 188:1997;134-146.
23. Yeo T.T., Yang T., Massa S.M., Zhang J.S., Honkaniemi J., Butcher L.L., Longo F.M. Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation. J. Neurosci. Res. 47:1997;348-360.
24. Zabolotny J.M., Kim Y.B., Peroni O.D., Kim J.K., Pani M.A., Boss O., Klaman L.D., Kamatkar S., Shulman G.I., Kahn B.B., Neel B.G. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proc. Natl. Acad. Sci. USA. 98:2001;5187-5192.
25. Arrandale J.M., Gore-Willse A., Rocks S., Ren J.M., Zhu J., Davis A., Livingston J.N., Rabin D.U. Insulin signaling in mice expressing reduced levels of Syp. J. Biol. Chem. 271:1996;21353-21358.
26. Moller N.P., Moller K.B., Lammers R., Kharitonenkov A., Hoppe E., Wiberg F.C., Sures I., Ullrich A. Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases α and ε J. Biol. Chem. 270:1995;23126-23131.
27. Harder K.W., Moller N.P., Peacock J.W., Jirik F.R. Protein-tyrosine phosphatase α regulates src family kinases and alters cell-substratum adhesion. J. Biol. Chem. 273:1998;31890-31900.
28. Lammers R., Moller N.P., Ullrich A. The transmembrane protein tyrosine phosphatase α dephosphorylates the insulin receptor in intact cells. FEBS Lett. 404:1997;37-40.
29. Lammers R., Moller N.P.H., Ullrich A. Mutant forms of the protein tyrosine phosphatase α show differential activities towards intracellular substrates. Biochem. Biophys. Res. Commun. 242:1998;32-38.
30. Jacob K.K., Sap J., Stanley F.M. Receptor-like protein-tyrosine phosphatase α specifically inhibits insulin-increased prolactin gene expression. J. Biol. Chem. 273:1998;4800-4809.
31. Cong L.-N., Chen H., Li Y., Lin C.H., Sap J., Quon M.J. Overexpression of protein tyrosine phosphatase-α but not PTP-κ inhibits translocation of GLUT4 in rat adipose cells. Biochem. Biophys. Res. Commun. 255:1999;200-207.
32. Arnott C.H., Sale E.M., Miller J., Sale G.J. Use of an antisense strategy to dissect the signaling role of protein-tyrosine phosphatase α J. Biol. Chem. 274:1999;26105-26112.
33. Pallen C.J. Protein tyrosine phosphatase alpha (PTPα): a src family kinase activator and mediator of multiple biological effects. Curr. Top. Med. Chem. 3:2003;821-835.
34. Lu H., Shah P., Ennis D., Shinder G., Sap J., Le-Tien H., Fantus I.G. The differentiation of skeletal muscle cells involves a protein-tyrosine phosphatase-alpha-mediated C-Src signaling pathway. J. Biol. Chem. 277:2002;46687-46695.
35. Ponniah S., Wang D.Z.M., Lim K.L., Pallen C.J. Targeted disruption of the tyrosine phosphatase PTPα leads to constitutive downregulation of the kinases src and fyn. Curr. Biol. 9:1999;535-538.
36. Sesti G., Federici M., Hribal M.L., Lauro D., Sbraccia P., Lauro M. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15:2001;2099-2111.